GROUP 4 Info - VIRGINIA MEDICAL PRACTICE

COVID-19 Vaccination Rollout Programme - Group 4

People aged 16 to 69 who are at very high risk

List of conditions
Cancer
All cancer patients actively receiving (and/or within 6 weeks of receiving) systemic therapy with cytotoxic chemotherapy, targeted therapy, monoclonal antibodies or immunotherapies and radical surgery or radiotherapy for lung or head and neck cancer.
All patients with advanced/metastatic cancers.

Chronic kidney disease
Chronic kidney disease, on dialysis, or eGFR <15 ml/min.

Chronic neurological disease or condition
Chronic neurological disease or condition with evolving ventilatory failure (requiring non-invasive ventilation), for example: motor neurone disease, spinal muscular atrophy.

Chronic respiratory disease
Chronic severe respiratory disease, for example: severe cystic fibrosis, severe COPD, severe pulmonary fibrosis.

Diabetes
Diabetes and HbA1C ≥58mmol/mol

Immunocompromised
Severe immunocompromise due to disease or treatment, for example:
·         transplantation: - Listed for solid organ or haematopoietic stem cell transplant (HSCT) - Post solid organ transplant at any time - Post HSCT within 12 months
·         genetic diseases: - APECED** - Inborn errors in the interferon pathway
·         treatment: - included but not limited to Cyclophosphamide, Rituximab, Alemtuzumab, Cladribine or Ocrelizumab in the last 6 months

Inherited metabolic diseases*
Disorders of intermediary metabolism/at risk of acute decompensation, for example: Maple Syrup Urine Disease.

Intellectual disability*
Down Syndrome.

Obesity
BMI >40 Kg/m2.
Sickle cell disease*

Source gov.ie